Can Prolonged Ischemia Time in Extremity Transfer Be Resolved Using an Extracorporeal Circulation Model? An...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Surgical Innovation

Background:

• Standard cold ischemic transport (CIT) for limb preservation is limited by incomplete prevention of ischemia-reperfusion injury (IRI).
• Extracorporeal perfusion (ECP) offers a potential alternative by maintaining a metabolic environment for ischemic tissues.
• Investigating ECP's efficacy against IRI compared to CIT is crucial for advancing transplantation and replantation techniques.

Purpose of the Study:

• To compare the effectiveness of extracorporeal perfusion (ECP) versus cold ischemic transport (CIT) in mitigating ischemia-reperfusion injury (IRI).
• To evaluate the impact of ECP and CIT on oxidative stress, inflammation, apoptosis, and tissue damage in an ischemia-reperfusion model.

Main Methods:

• Utilized an ischemia-reperfusion model with a 6-hour ischemia and 1-hour reperfusion period.
• Assessed biochemical markers of oxidative damage (superoxide dismutase, catalase, total antioxidant/oxidant status, total thiol) and inflammation (TNF-α, NF-κB, IL-10).
• Evaluated apoptosis via Bax and Bcl-2 protein levels and performed histopathologic examination, including mitochondrial assessment via Cox staining.

Main Results:

• ECP exhibited significantly less oxidative and inflammatory damage compared to CIT.
• Biochemical parameters indicative of damage were elevated in the CIT group.
• Histopathologic analysis revealed greater mitochondrial damage in tissues subjected to CIT.

Conclusions:

• ECP demonstrates superior outcomes in reducing inflammatory and oxidative damage compared to CIT.
• The findings support the potential clinical application of ECP for extremity transport to minimize histopathologic damage.
• ECP represents a promising strategy for improving tissue viability and outcomes in limb transplantation and replantation.